Archive for the ‘Clinical Chemistry’ Category
Humanized Coarse Models to Enquiry Opiate Metabolism: No Longer a “Chimera”? [Editorials] <<>>
Written by Botre, F. on September 29, 2009 – 12:00 am -Tags: chemistry, clinic
Posted in Clinical Chemistry | Comments Off
Unexpected Urine Medication Testing Results in a Hospice Passive on High-Dose Morphine Psychotherapy [Clinical Carton Study] <<>>
Written by Reisfield, G. M., Chronister, C. W., Goldberger, B. A., Bertholf, R. L. on September 29, 2009 – 12:00 am -Tags: chemistry, clinic
Posted in Clinical Chemistry | Comments Off
Commentary [Commentaries] <<>>
Written by Broussard, L. A. on September 29, 2009 – 12:00 am -Tags: chemistry, clinic
Posted in Clinical Chemistry | Comments Off
Commentary [Commentaries] <<>>
Written by Gourlay, D., Heit, H. A. on September 29, 2009 – 12:00 am -Tags: chemistry, clinic
Posted in Clinical Chemistry | Comments Off
Pharmacogenomics of Tamoxifen Treatment [Review] <<>>
Written by Brauch, H., Murdter, T. E., Eichelbaum, M., Schwab, M. on September 29, 2009 – 12:00 am -Background: Tamoxifen is a touchstone endocrine treatment for the slowing and treatment of steroid hormone receptor–positive bust cancer.
Content: Tamoxifen requires enzymatic activation by cytochrome P450 (CYP) enzymes for the materialization of functioning metabolites 4-hydroxytamoxifen and endoxifen. As compared with the old man drug, both metabolites deliver an generally 100-fold greater connection for the estrogen receptor and the facility to hold back stall rise. The polymorphic CYP2D6 is the key enzyme in this biotransformation, and latest mechanistic, pharmacologic, and clinical manifestation suggests that genetic variants and numb interaction by CYP2D6 inhibitors alter the plasma concentrations of functioning tamoxifen metabolites and the outcomes of tamoxifen-treated patients. In particular, nonfunctional (poor metabolizer) and fully impaired (intermediate metabolizer) CYP2D6 alleles are associated with higher recurrence rates.
Summary: Accordingly, CYP2D6 (cytochrome P450, family tree 2, subfamily D, polypeptide 6) genotyping prior to treatment to forecast metabolizer standing may spacious new avenues for individualizing endocrine treatment, with the uttermost help being expected for nationwide metabolizers. Moreover, tough CYP2D6 inhibitors such as the picky serotonin reuptake inhibitors paroxetine and fluoxetine, which are old to wine hot flashes, should be avoided because they entirely weaken organization of the efficacious metabolites.
<<>>Tags: chemistry, clinic
Posted in Clinical Chemistry | Comments Off
uPA+/+-SCID Mouse with Humanized Liver as a Form for In Vivo Metabolism of Exogenous Steroids: Methandienone as a Covering Investigate [Endocrinology and Metabolism] <<>>
Written by Lootens, L., Meuleman, P., Pozo, O. J., Van Eenoo, P., Leroux-Roels, G., Delbeke, F. T. on September 29, 2009 – 12:00 am -Background: Middling detection of schemer steroids in the urine of athletes is pacify a confrontation in doping self-discipline enquiry and requires instruction of steroid metabolism. In this read we investigated whether uPA+/+-SCID mice carrying functioning pure soul hepatocytes in their liver would afford a correct substitute skimpy uncultured form for the probe of Possibly manlike steroid metabolism in vivo.
Methods: A quantitative method based on transparent chromatography–tandem scads spectrometry (LC-MS/MS) was developed and validated for the urinary detection of 7 known methandienone metabolites. Germaneness of this method to urine samples from humanized mice after methandienone furnishing allowed for comparability with figures from in vivo somebody samples and with reported methandienone materials from in vitro hepatocyte cultures.
Results: The LC-MS/MS method validation in mouse and hominid urine indicated salubrious linearity, precision, and recapture. Using this method we quantified 6 of 7 celebrated woman methandienone metabolites in the urine of chimeric mice, whereas in tranquillity nonchimeric mice we detected simply 2 metabolites. These results correlated sheerest right with methandienone metabolism in humans. In addition, we detected 4 isomers of methandienone metabolites in both generous and chimeric mouse urine. One of these isomers has not at any time been reported in the future.
Conclusions: The results of this proof-of-concept swat point out that the altruist liver–uPA+/+-SCID mouse appears to be a satisfactory Lilliputian unrefined working model for the interrogation of human-type metabolism of anabolic steroids and perhaps also for other types of drugs and medications..
<<>>Tags: chemistry, clinic
Posted in Clinical Chemistry | Comments Off
Circulating Concentrations of Follistatin-Like 1 in Shape Individuals and Patients with Astute Coronary Syndrome as Assessed by an Immunoluminometric Sandwich Assay [Endocrinology and Metabolism] <<>>
Written by Widera, C., Horn-Wichmann, R., Kempf, T., Bethmann, K., Fiedler, B., Sharma, S., Lichtinghagen, R., Leitolf, H., Ivandic, B., Katus, H. A., Giannitsis, E., Wollert, K. C. on September 29, 2009 – 12:00 am -Background: Follistatin-like 1 (FSTL1) is a 308–amino acid secreted glycoprotein. Interweaving levels of FSTL1 are induced in brute models and patients with inveterate demagogic and cardiovascular virus. We hypothesized that FSTL1 can be deliberate in the tender motion and habituated to as a biomarker in sudden coronary syndrome (ACS).
Methods: We developed an immunoluminometric assay (ILMA), assessed the preanalytic characteristics of FSTL1, and single-minded circulating FSTL1 concentrations in 120 ostensibly salutary individuals and 216 patients with ACS.
Results: The assay had a limit of detection of 0.17 µg/L, limit of quantification of 1.02 µg/L, intraassay imprecision of ≤12.7%, and interassay imprecision of ≤15.4%. Selectivity was demonstrated with size-exclusion chromatography and deficit of cross-reactivity with common proteins. The assay was not appreciably influenced by foreign biological substances. FSTL1 in serum or everything blood was sure at allowance temperature for 48 h and was opposed to 4 freeze-thaw cycles. Uniform FSTL1 concentrations in citrated plasma and heparin-treated plasma were 18% and 17% lower, respectively, than concentrations clockwork in serum. Patently bracing individuals presented with a median FSTL1 serum concentration of 7.18 (range 1.06–18.49) µg/L. Serum FSTL1 concentrations were increased in ACS and reciprocal to the chance of all-cause mortality during follow-up.
Conclusions: The ILMA permits detection of FSTL1 in mortal serum and plasma. We anticipate that the favorable preanalytic characteristics of FSTL1 and the insinuation limits defined here for outwardly in the pink individuals pleasure help time to come studies of FSTL1 as a biomarker in different plague settings, including ACS.
<<>>Tags: chemistry, clinic
Posted in Clinical Chemistry | Comments Off
Maturation of an Immunoassay for the Quantification of Soluble LR11, a Circulating Marker of Atherosclerosis [Proteomics and Protein Markers] <<>>
Written by Matsuo, M., Ebinuma, H., Fukamachi, I., Jiang, M., Bujo, H., Saito, Y. on September 29, 2009 – 12:00 am -Background: Vascular crafty muscle cells (SMCs) go from the arterial media to the intima in the course of atherosclerosis, and dysfunction of SMCs leads to enhanced atherogenesis. A soluble character of the LDL receptor interrelated with 11 ligand-binding repeats (sLR11) is produced by the intimal SMCs, and the circulating concentrations of sLR11 like as not reproduce the pathophysiological fitness of intimal SMCs. Furthermore, polymorphism of the LR11 gene has been create to be affiliated to the start of Alzheimer blight. This office describes the improvement of a sandwich immunoassay for quantifying sLR11 in sympathetic serum and cerebrospinal ichor.
Methods: We reach-me-down plastic peptides or DNA immunization to display monoclonal antibodies (MAbs) A2-2–3, M3, and R14 against other epitopes of LR11.
Results: sLR11 was immunologically identified as a 250-kDa protein in philanthropist serum and cerebrospinal unfixed by SDS-PAGE separation, and was purified from serum by use of a receptor-associated protein and MAb M3. An immunoassay for quantification of sLR11 with a working lot of 0.25–4.0 µg/L was developed using the conglomeration of MAbs M3 and R14. Treatment of serum with 5.25% n-nonanoyl-N-methyl-d-glucamine reduced the matrix effects of serum on the absorbance detection in the ELISA technique. The linear energetic kind of the ELISA spanned the alteration of circulating sLR11 concentrations in individuals with atherosclerosis.
Conclusions: A sandwich ELISA was well-founded for quantifying sLR11 in serum and cerebrospinal formless. This aptitude provides a unusual means for assessing the pathophysiology of atherosclerosis, and at all neurodegenerative diseases.
<<>>Tags: chemistry, clinic
Posted in Clinical Chemistry | Comments Off
Short- and Long-Term Hazard Stratification Using a Next-Generation, High-Sensitivity Inquiry Cardiac Troponin I (hs-cTnI) Assay in an Predicament Activity be contingent Coffer Dolour Citizenry [Proteomics and Protein Markers] <<>>
Written by Kavsak, P. A., Wang, X., Ko, D. T., MacRae, A. R., Jaffe, A. S. on September 29, 2009 – 12:00 am -Background: The next-generation, high-sensitivity cardiac troponin assays can limitation quantifiable concentrations of cTn in a bulk of individuals, but there are few studies assessing these assays for gamble stratification. The these days writing-room was undertaken to infer if a analysis hs-cTnI assay can be usable for predicting death/myocardial infarction (MI), both short- and long-term, in an crisis hinge on ingenious coronary syndrome (ACS) populace.
Methods: In a squadron of 383 subjects, at recruited in 1996, presenting to the exigency area with symptoms suggestive of ACS, the heparin plasma obtained at sign bestowal was thawed and clockwork in 2007 with a probing hs-cTnI assay. AccuTnI (Beckman Coulter) measurements were made to measure on these unmodified samples in 2003. The natives was divided into 4 groups by hs-cTnI: <5.00, 5.00–9.99, 10.00–40.00, and >40.00 ng/L. Kaplan–Meier, Cox proportioned hazards, ROC curves, and logistic regression analyses were hardened to recognize empathize with which hs-cTnI concentrations were predictive of death/MI within 10 years after launch.
Results: There were substantive differences internuncio the hs-cTnI groups for the likeliness of death/MI up to 10 years after show (P < 0.05). At 6 months, patients with hs-cTnI ≥10.00 ng/L were at higher endanger for death/MI (hazard relationship >3.7; P < 0.05) compared with those having hs-cTnI <5.00 ng/L. ROC curve scrutiny for death/MI at 30 days with the hs-cTnI assay had an bailiwick below the curve of 0.74 (95% CI 0.65–0.82), with logistic models docile an optimal assay commencement of 12.68 ng/L.
Conclusions: This fact-finding hs-cTnI assay appears valuable for jeopardize stratification for death/MI in an ACS citizens.
<<>>Tags: chemistry, clinic
Posted in Clinical Chemistry | Comments Off
Intend and Optimization of Reverse-Transcription Quantitative PCR Experiments [Molecular Diagnostics and Genetics] <<>>
Written by Tichopad, A., Kitchen, R., Riedmaier, I., Becker, C., Stahlberg, A., Kubista, M. on September 29, 2009 – 12:00 am -Background: Quantitative PCR (qPCR) is a valuable competence for accurately and reliably profiling and quantifying gene word. Typically, samples obtained from the body of deliberate over bear to be processed via a few preparative steps in preference to QPCR.
Method: We estimated the errors of specimen withdrawal and extraction, alter transcription (RT), and QPCR that are introduced into measurements of MRNA concentrations. We performed hierarchically arranged experiments with 3 animals, 3 samples, 3 RT reactions, and 3 QPCRs and quantified the ardour of individual genes in strong tissue, blood, stall culture, and unmarried cells.
Results: A nested ANOVA form was old to likeness the experiments, and appurtenant to and unqualified errors were intentional with this sitter for each processing knock down in the hierarchical motif. We inaugurate that intersubject differences became indisputably confounded by illustrative heterogeneity for separate cells and whole chain. In stall cultures and blood, the bruit about from the RT and QPCR steps contributed in large measure to the inclusive howler because the sampling bawling was less strong.
Conclusions: We vouch for the use of trial replicates preferentially to any other replicates when working with swarming tissue, cubicle cultures, and sole cells, and we propound the use of RT replicates when working with blood. We display how an optimal sampling aim can be fitted for a circumscribed budget..
<<>>Tags: chemistry, clinic
Posted in Clinical Chemistry | Comments Off
Commensuration of Ribosomal RNA Volume In Vivo by Use of Deuterium-Labeled Glucose [Automation and Analytical Techniques] <<>>
Written by Defoiche, J., Zhang, Y., Lagneaux, L., Pettengell, R., Hegedus, A., Willems, L., Macallan, D. C. on September 29, 2009 – 12:00 am -Background: Most methods for regard of rates of RNA effort are not apropos in kindly in vivo clinical studies. We specify here an access for measuring ribosomal RNA gross revenue in vivo using [6,6-2H2]-glucose as a herald for de novo RNA composition. Because this method involves neither radioactivity nor toxic metabolites, it is applicable for individual studies.
Methods: For method unfolding in vitro, a lymphocyte room in conformity (PM1) was cultured in the appearance of [6,6-2H2]-glucose. RNA was extracted, hydrolyzed enzymatically to ribonucleosides, and derivatized to either the aldonitrile tetra-acetate or the pentafluoro triacetate procured of the pentose already GC-MS. We identified peerless derivatization and scrutiny conditions and demonstrated quantitative incorporation of deuterium from glucose into RNA of dividing cells.
Results: Drive clinical studies demonstrated the applicability of this closer to blood leukocytes and powerful tissues. A unfailing with confirmed lymphocytic leukemia received [6,6-2H2]-glucose (1 g/kg) orally in aliquots administered every 30 min for a patch of 10 h. When we analyzed CD3– B cells that had been purified by gradient centrifugation and magnetic-bead adhesion, we observed deuterium enrichment, a judgement conforming with a ribosomal RNA effort anyhow of reciprocity 7%/day, undeterred by the stolid boundary line rates observed in concurrent DNA-labeling opinion. Similarly, in 2 patients with spiteful infiltration of lymph nodes, superintendence of [6,6-2H2]-glucose (by intravenous infusion for 24 h) in preference to excision biopsy allowed admiration of DNA and RNA total business in lymph node samples.
Conclusions: Our haunt results rally the proof-of-principle that deuterium-labeled glucose may be hand-me-down to analyze RNA turnover, in besides to DNA production/cell proliferation, in clinical samples.
<<>>Tags: chemistry, clinic
Posted in Clinical Chemistry | Comments Off
Increased Pile Constituent Look Is Associated with Reduced Survival in Non-Small Chamber Lung Cancer and with Mutations of TP53 and PTEN [Cancer Diagnostics] <<>>
Written by Regina, S., Valentin, J.-B., Lachot, S., Lemarie, E., Rollin, J., Gruel, Y. on September 29, 2009 – 12:00 am -Background: Combination particular (TF), the power initiator of blood coagulation, is also a signaling protein that regulates cancer making. TF mixing was recently shown to be artificial by tumor suppressor genes (TSGs) in tumor stall lines. We thus planned TF gene (F3) phraseology and the pre-eminence of genes coding for tumor protein p53 (TP53), phosphatase and tensin homolog (PTEN), and serine/threonine kinase 11 (STK11) in non–small stall lung cancer (NSCLC). Heparanase (HPSE) gene aspect was also premeditated because this endo-β-D-glucuronidase was recently shown to swell TF gene assertion.
Methods: TF and heparanase MRNA language was steady by real-time PCR in 53 NSCLC tumors. Exons 5–8 of TP53 were sequenced from genomic DNA. Mutations of PTEN and STK11 were screened by multiplex ligation-dependent around amplification.
Results: TF MRNA levels were significantly higher in T3–T4 tumors (P = 0.04) and in stages III–IV of NSCLC (P = 0.03). Mutations of TP53, STK11, and PTEN were identified in 20 (37.7%), 21 (39%), and 20 (37.7%) of tumors, mutatis mutandis. TF appearance was higher in mutated TP53 (TP53Mut) (P = 0.02) and PTENMut (P = 0.03) samples. Moreover, TF MRNA increased from 2700 copies (no mutation) to 11 6415 when 3 TSG were mutated. Heparanase gene utterance did not diverge according to TF gene (F3) look or TSG modification. The median survival schedule was shorter in patients with tumor TF MRNA levels in excess of median values (relative chance 2.2; P = 0.03, multivariate analysis) and when TP53 was mutated (relative chance 1.8; P = 0.02).
Conclusions: These results yield run off demonstrate that combined oncogene events affecting TSG dramatically raise TF gene manifestation in lung tumors. Moreover, this workroom suggests that TF gene turn of phrase could be tolerant of as a prognostic marker in NSCLC..
<<>>Tags: chemistry, clinic
Posted in Clinical Chemistry | Comments Off
New ELISA for B Cell-Activating Part [Clinical Immunology] <<>>
Written by Le Pottier, L., Bendaoud, B., Renaudineau, Y., Youinou, P., Pers, J.-O., Daridon, C. on September 29, 2009 – 12:00 am -Background: The B cell–activating financier of the TNF brood (BAFF) is upregulated in autoimmune diseases, but a mob of conflicting results procure hint doubts on the reliability of the ELISA protocols currently acclimatized for its quantification. This position led us to result a new ELISA for the valuation of BAFF.
Methods: BAFF was purified for use alongside nonglycosylated recombinant BAFF. Two monoclonal antibodies (mAbs) and two polyclonal antibodies (pAbs) to BAFF were second-hand.
Results: The optimization make showed that the pAb appearance was preferable to the mAb aspect as pinch antibody, because the PAbs recognized the glycosylated as approvingly as the nonglycosylated forms of BAFF. The most proficient dyad of Abs interested using the unconjugated invent of a goat pAb to seizure BAFF and the uniform biotinylated goat pAb to Hawkshaw predestined BAFF. This ELISA was not influenced by the self-possession of rheumatoid moneylender.
Conclusions: This new ELISA helped take precautions insights into why serum concentrations of BAFF differ mediator studies for a accustomed natives of patients. It is a trusty means for the direction of the diseases in which BAFF is an signs of comeback to remedial programme.
<<>>Tags: chemistry, clinic
Posted in Clinical Chemistry | Comments Off
Methylation Significance and Neurodegenerative Markers in Parkinson Condition [General Clinical Chemistry] <<>>
Written by Obeid, R., Schadt, A., Dillmann, U., Kostopoulos, P., Fassbender, K., Herrmann, W. on September 29, 2009 – 12:00 am -Background: Increased concentrations of plasma outright homocysteine (tHcy) father been associated with age-related diseases, including dementia, stroke, and Parkinson malady (PD). Methylation standing energy constituent Hcy metabolism to neurodegenerative proteins in patients with PD.
Methods: We tested blood samples from 87 patients with PD (median age 68 years; 35 men) for tHcy, methylmalonic acid (MMA), vitamin B12, vitamin B6, folate, S-adenosyl methionine (SAM), S-adenosyl homocysteine (SAH), and amyloid-β(1–42). We sedate citrate blood from a subset of 45 patients to get platelet-rich plasma, and we cast-off washed platelets to build room extracts for amyloid herald protein (APP) and -synuclein assays. We worn perception parenchyma sonography to guess the substantia nigra echogenic square in a subset of 59 patients.
Results: Serum concentrations of THcy were increased in PD patients (median 14.8 µmol/L). THcy (β coefficient = –0.276) and serum creatinine (β = –0.422) were expressive predictors of the proportion of SAM/SAH in plasma (P < 0.01). The plasma SAM/SAH correlation was a eloquent determinant for DemTect scores (β = 0.612, P = 0.004). Relevant adversarial correlations were base middleman concentrations of SAH in plasma and platelet APP and liaison SAM and platelet -synuclein. A larger echogenic range of the substantia nigra was kin to higher serum concentrations of MMA (P = 0.016).
Conclusions: Markers of neurodegeneration (APP, -synuclein) are interconnected to markers of methylation (SAM, SAH) in patients with PD. Best cognitive ritual was coupled to higher methylation latent (SAM/SAH ratio).
<<>>Tags: chemistry, clinic
Posted in Clinical Chemistry | Comments Off
Interactive Modeling for Endless Utility of Pharmacogenetic Diagnostic Testing: Industriousness for Warfarin Remedial programme [Hemostasis and Thrombosis] <<>>
Written by Linder, M. W., Bon Homme, M., Reynolds, K. K., Gage, B. F., Eby, C., Silvestrov, N., Valdes, R. on September 29, 2009 – 12:00 am -Background: The relevance of pharmacogenetic results requires apparent correlations medium a prove evolve and an indicated well-defined advance of skirmish. We developed a computational decision-support instrumentality that combines patient-specific genotype and phenotype info to give critical dosage counsel. This tool, auspices of estimating quantitative and profane parameters associated with the metabolism- and concentration-dependent retort to warfarin, provides the vital patient-specific framework for interpreting global normalized correlation (INR) measurements.
Methods: We analyzed clinical information, plasma S-warfarin concentration, and CYP2C9 (cytochrome P450, kindred 2, subfamily C, polypeptide 9) and VKORC1 (vitamin K epoxide reductase complex, subunit 1) genotypes for 137 patients with steadfast INRs. Plasma S-warfarin concentrations were evaluated by VKORC1 genotype (–1639G>A). The steady-state plasma S-warfarin concentration was planned with CYP2C9 genotype–based margin rates and compared with genuine measurements.
Results: The plasma S-warfarin concentration required to takings the goal INR rejoinder is significantly (P < 0.05) associated with VKORC1 –1639G>A genotype (GG, 0.68 mg/L; AG, 0.48 mg/L; AA, 0.27 mg/L). Modeling of the plasma S-warfarin concentration according to CYP2C9 genotype predicted 58% of the diversification in quantified S-warfarin concentration: Leisurely [S-warfarin] = 0.67(Estimated [S-warfarin]) + 0.16 mg/L.
Conclusions: The objective spell of plasma S-warfarin concentration required to hand in a salubrious INR can be predicted from the VKORC1 genotype (pharmacodynamics), and the reformer changes in S-warfarin concentration after repeated habitually dosing can be predicted from the CYP2C9 genotype (pharmacokinetics). Combining the assiduity of multivariate equations for estimating the sustentation dispense with genotype-guided pharmacokinetics/pharmacodynamics modeling provides a sturdy agency for maximizing the value of CYP2C9 and VKORC1 evaluation results for unbroken devotion to long-suffering fret.
<<>>Tags: chemistry, clinic
Posted in Clinical Chemistry | Comments Off
